CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Cohlhepp Ryan President, COO & Interim CEO | Option exercise 10b5-1 | +17,500 | $3.79 | $66K | 199,141 |
| 2026-09-08 | Cohlhepp Ryan President, COO & Interim CEO | Sale 10b5-1 | −14,058 | $22.77 | $320K | 185,083 |
| 2026-09-08 | Cohlhepp Ryan President, COO & Interim CEO | Sale 10b5-1 | −3,442 | $23.43 | $81K | 181,641 |
| 2026-09-08 | Cohlhepp Ryan President, COO & Interim CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,500 | 34,252 | ||
| 2026-08-10 | Cohlhepp Ryan President and COO | Option exercise 10b5-1 | +18,750 | $3.79 | $71K | 200,391 |
| 2026-08-10 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −18,750 | $27.98 | $525K | 181,641 |
| 2026-08-10 | Cohlhepp Ryan President and COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,750 | 51,752 | ||
| 2026-07-09 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −536 | $29.00 | $16K | 181,641 |
| 2026-07-08 | Cohlhepp Ryan President and COO | Option exercise 10b5-1 | +18,750 | $3.79 | $71K | 210,391 |
| 2026-07-08 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −22,833 | $28.76 | $657K | 187,558 |
| 2026-07-08 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,306 | $29.80 | $128K | 183,252 |
| 2026-07-08 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −1,075 | $30.35 | $33K | 182,177 |
| 2026-07-08 | Cohlhepp Ryan President and COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,750 | 70,502 | ||
| 2026-05-15 | Cohlhepp Ryan President and COO | Option exercise 10b5-1 | +8,000 | $3.79 | $30K | 204,141 |
| 2026-05-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $20.29 | $162K | 196,141 |
| 2026-05-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $20.29 | $91K | 191,641 |
| 2026-05-15 | Cohlhepp Ryan President and COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,000 | 101,334 | ||
| 2026-04-15 | Cohlhepp Ryan President and COO | Option exercise 10b5-1 | +8,000 | $3.79 | $30K | 208,641 |
| 2026-04-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $23.01 | $184K | 200,641 |
| 2026-04-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $23.01 | $104K | 196,141 |
Page 1 of 3 · 58 trades